picric acid has been researched along with Autoimmune Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Hirose, S; Kayagaki, N; Okumura, K; Shirai, T; Yagita, H; Yamaguchi, N | 1 |
| de Zoeten, EF; Hancock, WW | 1 |
| Mihara, M; Moriya, Y; Takagi, N; Takeda, Y; Urakawa, K | 1 |
| Diener, E; Diner, UE; Sinha, A; Vergidis, R; Xie, S | 1 |
1 trial(s) available for picric acid and Autoimmune Disease
| Article | Year |
|---|---|
A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.
Topics: 2-Aminoadipic Acid; Administration, Oral; Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Blood Urea Nitrogen; Cell Division; Cholesterol; DNA, Single-Stranded; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Kidney Diseases; Lupus Nephritis; Lymph Nodes; Methotrexate; Mice; Mice, Inbred MRL lpr; Picrates; Proteinuria; Specific Pathogen-Free Organisms; Spleen | 1997 |
3 other study(ies) available for picric acid and Autoimmune Disease
| Article | Year |
|---|---|
Suppression of antibody production by TNF-related apoptosis-inducing ligand (TRAIL).
Topics: Animals; Antibodies; Antibodies, Monoclonal; Apoptosis; Apoptosis Regulatory Proteins; Autoantibodies; Autoimmune Diseases; CD4 Antigens; CD8 Antigens; Fas Ligand Protein; Female; Immunoglobulin G; Injections, Intraperitoneal; Lymphoma, B-Cell; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Mutant Strains; Mutation; Picrates; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha | 2002 |
Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
Topics: Animals; Autoimmune Diseases; Bystander Effect; Cell Movement; Colitis; Colon; Disease Models, Animal; Forkhead Transcription Factors; Immunity, Mucosal; Immunotherapy, Adoptive; Intestinal Mucosa; Lymphocyte Activation; Mice; Mice, Transgenic; Oxazolone; Picrates; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; T-Lymphocytes, Regulatory; Time Factors; Trinitrobenzenesulfonic Acid | 2008 |
Specific immunosuppression by immunotoxins containing daunomycin.
Topics: Animals; Autoimmune Diseases; Concanavalin A; Daunorubicin; Fluorescein; Fluoresceins; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred CBA; Nitrohydroxyiodophenylacetate; Ovalbumin; Picrates; Spleen; T-Lymphocytes | 1986 |